Fierce Biotech April 25, 2024
Parexel has struck a multi-year deal with Palantir Technologies to integrate its artificial intelligence systems into Parexel’s clinical trial operations. The companies did not disclose the deal’s financial terms.
Palantir is a software behemoth co-founded by billionaire and “PayPal mafia don” Peter Thiel. While the deal with Parexel marks Palantir’s first foray into contract research organizations, the company’s technology is already seemingly everywhere else, from national defense systems, hospitals and telecommunications to anti-money laundering operations and retail.
“Palantir’s Foundry and Artificial Intelligence Platform [AIP] are particularly suited to enhance and accelerate the delivery of safe and effective clinical trials and capable of doing so—at scale,” Dan Ballard, senior vice president of digital enablement and innovation at Parexel, told Fierce...
Today's Sponsors
Today's Sponsor